Skip to main content

DPHARM: Disruptive Innovations to Advance Clinical Research

Please join Yseop at DPHARM in Boston, MA this September 13-14 at Booth 28. If you would like to schedule a meeting during the event, please fill out the form on the right. A Yseop representative will get in contact soon to schedule a convenient time to meet.

If attending, make sure to stop by our Innovation Sources & Solutions session on Tuesday, September 13 at 12:10pm EST, "Augment Medical Writing with AI."

  • Marjo Gazak of Eli Lilly will join to review how their team has adopted AI to augment various reporting workflows 
  • Emmanuel Walckenaer, CEO of Yseop, will discuss the future of work for life sciences teams and ways in which humans and technology can work together to create more efficient workforces
  • They will discuss the potential of pharmaceutical document augmentation and how AI is paving the way for a fully automated document landscape

About DPHARM

DPHARM® offers an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders unveil the latest innovations to modernize clinical trials. 

The Pandemic forced the industry to prioritize exactly what DPHARM focuses on: modernizing clinical trials.  For eleven years, DPHARM has been examining how trials can be re-imagined to be more efficient, more patient-focused, more accurate, quicker and less costly. This year, with Former FDA Commissioner Scott Gottlieb and Visionary Thinker Malcolm Gladwell as Keynote Speakers, the conference will challenge attendees to harness the industry's momentum to continue to change how clinical trials are operationalized and what they will look like in a post-Covid world. 

dpharm